Zymeworks Announces Participation in Upcoming Investor Conferences

GlobeNewswire

April 30, 2024



VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences: Bank of America Securities Health Care Conference: Zymeworks’ management will participate in one-on-one meetings on May 15th in Las Vegas, NV.J.P. Morgan Biotech Virtual Call Series: Zymeworks’ management will participate in a virtual fireside chat on May 15th at 10:00 am Pacific Time. About Zymeworks Inc.

Related

---